11,128 Shares in Corteva, Inc. $CTVA Bought by Capstone Investment Advisors LLC

Capstone Investment Advisors LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA) in the second quarter, Holdings Channel reports. The institutional investor acquired 11,128 shares of the company’s stock, valued at approximately $942,000.

Other hedge funds have also recently made changes to their positions in the company. Proficio Capital Partners LLC acquired a new stake in Corteva in the second quarter worth $662,000. Pure Financial Advisors LLC bought a new position in Corteva in the second quarter worth approximately $609,000. Transamerica Financial Advisors LLC acquired a new stake in Corteva in the second quarter valued at approximately $283,000. Corient Private Wealth LP acquired a new stake in Corteva in the second quarter valued at approximately $17,742,000. Finally, Ausdal Financial Partners Inc. bought a new stake in shares of Corteva during the second quarter valued at approximately $409,000. 81.54% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CTVA. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Mizuho lifted their target price on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday, July 14th. UBS Group dropped their price objective on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 18th. Finally, CICC Research increased their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Corteva Trading Down 0.7%

Shares of Corteva stock opened at $82.27 on Friday. The firm has a market cap of $54.89 billion, a PE ratio of 54.48, a P/E/G ratio of 2.54 and a beta of 0.57. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The stock has a fifty day moving average price of $82.58 and a 200-day moving average price of $80.52.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the company posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.